Clinical Trials
11 trialsNCT05071846 2026-04-14
MVX-ONCO-2 in Advanced Solid Tumors
University Hospital, Geneva
Phase 1 Active not recruiting
NCT05763004 2026-03-27
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
ImmunOs Therapeutics AG
Phase 1 Active not recruiting
NCT04221204 2026-03-25
A Monotherapy in Subjects With Advanced Solid Tumors
3D Medicines
Phase 1 Active not recruiting
NCT07137195 2026-02-27
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
Ion Beam Applications
Phase NA Active not recruiting
NCT07153094 2026-01-16
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)
Ion Beam Applications
Phase NA Active not recruiting
NCT04725474 2026-01-12
GDFATHER
CatalYm GmbH
Phase 1/2 Active not recruiting
NCT07152353 2026-01-07
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)
Ion Beam Applications
Phase NA Active not recruiting
NCT06462716 2025-04-13
A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors
Chengdu Baiyu Pharmaceutical Co., Ltd.
Phase 1 Active not recruiting
NCT04585035 2025-03-18
Study to Evaluate D-1553 in Subjects With Solid Tumors
InventisBio Co., Ltd
Phase 1/2 Active not recruiting
NCT04643574 2025-02-14
NeoTIL in Advanced Solid Tumors
Centre Hospitalier Universitaire Vaudois
Phase 1 Active not recruiting
NCT06026254 2024-11-18
A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial
ImmuneSensor Therapeutics Inc.
Phase 1 Active not recruiting